Announcement on the Cancellation of Settlement Accounts for Some Raised Capital Wealth Management Products
Announcement of the resolution of the 15th meeting of the second board of supervisors.
Independent financial advisor report on the granting of restricted stock incentives by Sinovac Biotech Co., Ltd. in 2024 as provided by Shanghai Rongzheng Enterprise Consulting (Group) Co., Ltd.
Announcement of the Resolution of the 16th Meeting of the Second Board of Directors.
Independent Financial Advisory Report of Shanghai Rongzheng Enterprise Consulting Service (Group) Co., Ltd. on the 2024 Restricted Stock Incentive Plan (Draft) of Kexing Biopharmaceutical Co., Ltd.
2024 Restricted Stock Incentive Plan Implementation Assessment Management Measures
Announcement of Resolutions of the 14th Meeting of the 2nd Board of Supervisors
Voluntary Disclosure Notice on Obtaining the GB08 Notice of Approval for Clinical Trials of Injectable Drugs
Resolutions of the Third Special Meeting of Independent Directors of the 2nd Board of Directors
Announcement of Resolutions of the 15th Meeting of the 2nd Board of Directors
Notice on Public Solicitation of Independent Directors' Right to Delegate Voting
Kexon Pharmaceutical Investor Relations Activity Record Form for May 2024
CITIC Construction Investment Securities Co., Ltd.'s 2023 Continuous Supervision and Follow-up Report on Kexing Biopharmaceutical Co., Ltd.
Announcement on attending the 2023 Science and Technology Innovation Board Pharmaceutical Special Group Performance Briefing and the First Quarter 2024 Results Briefing
Voluntary disclosure of the announcement on passing the EU GMP certification
Articles of Association
Rules of procedure for general shareholders' meetings
Rules of Procedure of the Supervisory Board
Independent director work system
Related transaction management system
No Data